Muscle biopsy and in vitro contracture test in subjects with idiopathic HyperCKemia

Anesthesiology

Volumn 109, Issue 4, 2008, Pages 625-628

  Malandrini, Alessandro ^c   Orrico, Alfredo ^b   Gaudiano, Carmen ^e   Gambelli, Simona ^e   Galli, Lucia ^b   Berti, Gianna ^e   Tegazzin, Vincenzo ^d   Dotti, Maria Teresa ^a   Federico, Antonio ^a   Sorrentino, Vincenzo ^c  

^a Unit of Neurometabolic Disease

^b Unit of Molecular Medicine

^c UNIVERSITY OF SIENA   (Italy)

^d S ANTONIO HOSPITAL   (Italy)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; RYANODINE RECEPTOR 1; RYANODINE RECEPTOR;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ELECTROMYOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IDIOPATHIC HYPERCKEMIA; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INBORN ERROR OF METABOLISM; MALE; MALIGNANT HYPERTHERMIA; MUSCLE BIOPSY; MUSCLE CONTRACTURE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; BIOPSY; BLOOD; GENETICS; MIDDLE AGED; MUSCLE CONTRACTION; PATHOLOGY; RETROSPECTIVE STUDY; SKELETAL MUSCLE;

ADOLESCENT; ADULT; AGED; BIOPSY; CHILD; CREATINE KINASE; FEMALE; HUMANS; MALE; MALIGNANT HYPERTHERMIA; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SKELETAL; RETROSPECTIVE STUDIES; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 54749098890     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181862a0d     Document Type: Article

References (14)

1. Afifi AK: Idiopathic hyperCKemia revisited. J Child Neurol 1998; 13:251-2
2. Weglinski MR, Wedel DJ, Engel AG: Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels. Anesth Analg 1997; 84:1038-41
3. Capasso M, De Angelis MV, Di Muzio A, Scarciolla O, Pace M, Stuppia L, Comi GP, Uncini A: Familial idiopathic hyper-CK-emia: An underrecognized condition. Muscle Nerve 2006; 33:760-5
4. European Malignant Hyperpyrexia Group: A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 1984; 56:1267-9
5. Fernandez C, de Paula AM, Figarella-Branger D, Kraha M, Giorgi R, Chabrol B, Monfort MF, Puoget J, Pelliser JF: Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia. Neurology 2006; 66:1585-7
6. Prelle A, Tancredi L, Sciacco M, Chiveri L, Comi GP, Battistel A, Bazzi P, Martinelli Boneschi F, Bagnardi V, Ciscato P, Bordoni A, Fortunato F, Strazzer S, Bresolin N, Scarlato G, Moggio M: Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. J Neurol 2002; 249:305-11
7. Simmons Z, Peterlin BL, Boyer PJ, Towfighi J: Muscle biopsy in the evaluation of patients with modestly elevated creatine kinase levels. Muscle Nerve 2003; 27:242-4
8. Britt BA, Endrenyi L, Peters PL, Kwong FH, Kadijevic L: Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations. Can Anaesth Soc J 1976; 23:263-84
9. Monnier N, Kozak-Ribbens G, Krivosic-Horber R, Nivoche Y, Qi D, Kraev N, Loke J, Sharma P, Tegazzin V, Figarella-Branger D, Romero N, Mezin P, Bendahan D, Payen JF, Depret T, Maclennan DH, Lunardi J: Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility. Hum Mutat 2005; 26:413-25
10. Ellis FR, Halsall PJ, Harriman DG: The work of a Leeds Malignant Hyper-pyrexia Unit, 1971-84. Anaesthesia 1986; 41:809-15
11. Lehmann-Horn F, Iaizzo PA: Are myotonias and periodic paralysis associated with susceptibility to malignant hyperthermia? Br J Anaesth 1990; 65:692-7
12. Mezin P, Payen F, Bosson L, Brambilla E, Stieglitz P: Histological support for the difference between malignant hyperthermia susceptible (MHS), equivocal (MHE) and negative (MHN) muscle biopsies. Br J Anaesth 1997; 78:327-31
13. von Breunig F, Wappler F, Hagel C, von Richthofen V, Fiege M, Weisshorn R, Stavrou D, Schulte am Esch J: Histomorphologic examination of skeletal muscle preparation does not differentiate between malignant hyperthermia- susceptible and normal patients. ANESTHESIOLOGY 2004; 100:789-94
14. Figarella-Branger D, Kozak-Ribbens G, Rodet L, Aubert M, Borsarelli J, Cozzone PJ, Pellisser JF: Pathological findings in 165 patients explored for malignant hyperthermia susceptibility. Neuromuscul Disord 1993; 3:553-6